$16.7 Billion Worldwide Cell Analysis Industry to 2027 - Impact of COVID-19 on the Market

DUBLIN, April 20, 2021 /PRNewswire/ -- The "Cell Analysis - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Cell Analysis estimated at US$16.7 Billion in the year 2020, is projected to reach a revised size of US$25.1 Billion by 2027, growing at a CAGR of 6% over the analysis period 2020-2027.

Flow Cytometry Products, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$7.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the qPCR Products segment is readjusted to a revised 6.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.5 Billion, While China is Forecast to Grow at 9.2% CAGR

The Cell Analysis market in the U.S. is estimated at US$4.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2027 trailing a CAGR of 9.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 5.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Cell Microarrays Segment to Record 5.9% CAGR

In the global Cell Microarrays segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.1 Billion in the year 2020 will reach a projected size of US$3.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.4 Billion by the year 2027, while Latin America will expand at a 7.1% CAGR through the analysis period.

Select Competitors (Total 33 Featured):

• Agilent Technologies
• Becton, Dickinson and Company
• Bio-Rad Laboratories
• Biostatus Limited
• Carl Zeiss
• Cell Biolabs, Inc
• Creative Bioarray
• Cytek Biosciences
• Danaher
• GE Healthcare (A Subsidiary of General Electric Company)
• Meiji Techno
• Merck KGaA
• Miltenyi Biotec
• Nanocellect Biomedical
• Olympus Corporation
• Perkinelmer
• Promega Corporation
• Sysmex Corporation
• Tecan Trading AG
• Thermo Fisher Scientific

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

• UNITED STATES
• CANADA
• JAPAN
• CHINA
• EUROPE
• FRANCE
• GERMANY
• ITALY
• UNITED KINGDOM
• SPAIN
• RUSSIA
• REST OF EUROPE
• ASIA-PACIFIC
• AUSTRALIA
• INDIA
• SOUTH KOREA
• REST OF ASIA-PACIFIC
• LATIN AMERICA
• ARGENTINA
• BRAZIL
• MEXICO
• REST OF LATIN AMERICA
• MIDDLE EAST
• IRAN
• ISRAEL
• SAUDI ARABIA
• UNITED ARAB EMIRATES
• REST OF MIDDLE EAST
• AFRICA

IV. COMPETITION

• Total Companies Profiled: 33

For more information about this report visit https://www.researchandmarkets.com/r/h69p1d

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets